北京时间：11月24日 21:30 - 22:15
Impact of commissural and coronary alignment on coronary cannulation after TAVI with Evolut FX
使用Evolut FX进行TAVI后，连合和冠脉对齐对冠状动脉插管的影响
Long-term results from International Chimney Stent Registry
国际”烟囱“支架注册研究的长期结果
DurAVR TAVI: biomimetic design restores flow and leads to significant left ventricular mass regression - MRI study
DurAVR TAVI：仿生设计恢复血流并导致左心室质量显著下降——MRI研究
US pivotal study of the Vivasure PerQseal system for large hole closure: PATCH
用于大口径血管闭合的Vivasure PerQseal系统的美国关键性研究：PATCH试验
Live case interventional cardiology procedures are safe: outcomes from a multicentre registry
介入心脏病学手术直播是安全的：多中心登记的结果
北京时间：11月24日 22:20 - 23:05
Five-year outcomes after AVR in low-risk patients stratified by annulus size
按瓣环大小分层的低风险患者行主动脉瓣置换术后的五年预后
Valve performance between the SAPIEN 3 Ultra RESILIA and Evolut FX in a small aortic annulus
SAPIEN 3 Ultra RESILIA和Evolut-FX在小主动脉瓣环中的瓣膜性能比较
Long-term clinical impact of paravalvular leak following TAVI
TAVI术后瓣周漏的长期临床影响
Clinical impact of frame underexpansion using a self-expanding transcatheter heart valve
使用自膨胀经导管心脏瓣膜对框架膨胀不良的临床影响
Clinical updates on the first dedicated leaflet splitting device prior TAVI
TAVI前首个专用瓣叶分离装置的临床最新进展
北京时间：11月24日 23:10 - 23:55
Real-world outcomes with initial clip selection of MitraClip G4 device from OCEAN-Mitral registry
来自OCEAN-Mitra注册研究中MitraClip G4装置的真实世界结果
Tricuspid regurgitation and 3-year mortality after treatment of mitral valve disease
三尖瓣反流与二尖瓣疾病治疗后的3年死亡率
Half moon posterior leaflet augmentation: early human experience
Half Moon后瓣叶加宽法：早期人类经验
HighLife transseptal mitral valve feasibility study: on-year outcomes of the first 45 patients
HighLife经房间隔二尖瓣可行性研究：首批45例患者的年内疗效
Left ventricular remodelling following transcatheter mitral valve replacement
经导管二尖瓣置换术后的左心室重塑
北京时间：11月25日 00:15 - 01:15
One-year results of a randomised study comparing two balloon expandable TAVI valves
比较两种球囊扩张型TAVI瓣膜的随机研究一年结果
30 days outcomes of transfemoral J-valve for chronic aortic regurgitation: a prospective, multicentre study in 127 cases
经股J-valve治疗慢性主动脉瓣反流的30天结局：127例患者的前瞻性多中心研究
TRISCEND II: transcatheter valve replacement vs. medical therapy for tricuspid regurgitation
TRISCEND II研究：三尖瓣反流患者经导管瓣膜置换术与药物治疗的比较
Bicaval TricValve in severe tricuspid regurgitation - One-year outcomes from the Tricbicaval registry
双腔TricValve在严重三尖瓣反流患者中的应用——Tricbicaval登记研究的一年结果
Two-year outcomes of mitral transcatheter edge-to-edge repair from the MiCLASP study
MiCLASP研究中经导管二尖瓣缘对缘修复术的两年结果
CLASP IID randomised trial and registry: two-year outcomes
CLASP IID随机试验和登记研究：两年结果
北京时间：11月25日 18:05 - 18:50
